摘要
狼疮肾炎(lupus nephritis,LN)是系统性红斑狼疮(systemic lupus erythematosus,SLE)中常见的并发症,其中10%~20%的LN患者会在确诊后5年内发展到终末期肾病,进而危及生命。磷脂酰肌醇3激酶(phosphatidylinositol 3 kinase,PI3K)/蛋白激酶B(protein kinase B,Akt)(简称PI3K/Akt信号通路)是细胞周期过程中重要的信号通路之一。近几年显示PI3K/Akt信号通路与LN的发生发展有关,文章总结了PI3K/Akt信号通路在LN中的机制研究和相关抑制剂,以期为LN的治疗靶点提供新的思路。
Lupus nephritis(LN)is a common complication of systemic lupus erythematosus(SLE),with 10%~20%of patients with LN developing the life-threatening end-stage renal disease within 5 years of diagnosis.Phosphatidylinositol 3 kinase(PI3K)/protein kinase B(Akt)(PI3K/Akt signaling pathway)is one of the important signaling pathways during the cell cycle.In recent years,it has been shown that PI3K/Akt signaling pathway is associated with the development of LN.The mechanistic studies of the PI3K/Akt signaling pathway in LN and related inhibitors,with a view to providing new ideas for therapeutic targets in LN were summarized.
作者
程芷洛
孟祥文
贾晓益
张敏
CHEN Zhiluo;MENG Xiangwen;JIA Xiaoyi;ZHANG Min(School of Pharmacy,Anhui University of Chinese Medicine,Hefei 230012,China;Department of Rheumatology&Immunology,the First Affiliated Hospital of USTC,Hefei 230001,China)
出处
《国际免疫学杂志》
CAS
2024年第2期178-182,共5页
International Journal of Immunology
基金
国家自然科学基金(82074090)
安徽省自然科学基金(1808085MH298)
中国博士后科学基金项目(2020M682051)
安徽省博士后科研活动资助项目(2021A480)。